Disitamab + ENVAFOLIMAB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Disitamab + ENVAFOLIMAB
Treatment and conditionWhere it standsTrials
Disitamab + ENVAFOLIMAB for prostatic neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1